Gene-modified pancreas cells offer hope for people with type 1 diabetes

Gene Editing and the Future of Pancreas Transplants: A Fresh Hope for Type 1 Diabetes Four weeks after transplanting genetically modified insulin-producing cells into a patient with type 1 diabetes, researchers at Uppsala University Hospital achieved a breakthrough: the transplanted cells were alive and functioning, despite the patient not taking any immune-system-suppressive drugs. This marks … Read more

Engineered proteins track gene expression in living primate brains

Revolutionizing Brain Research: Non-Invasive Monitoring Paves the Way for Personalized Therapies Gene therapy is already showing promise in treating conditions like immune deficiencies, hereditary blindness, hemophilia, and Huntington’s disease. Now, a groundbreaking advance published in Neuron is poised to accelerate this progress, offering a non-invasive window into the living brain. The Power of Released Markers … Read more

FDA Approves Pathway for Personalized Gene Editing Medicines

The Dawn of Bespoke Medicine: How Individualized Treatments Are Reshaping Healthcare The Food and Drug Administration (FDA) recently released guidance paving the way for the approval of the first truly personalized medicines, designed to address a patient’s unique genetic makeup. This shift, spearheaded by FDA Commissioner Marty Makary and biologics chief Vinay Prasad, marks a … Read more

Drinkable gene therapy foam for the treatment of constrictive esophageal carcinoma

What’s Next for Esophageal Cancer Care? Emerging Trends Shaping the Future Predictive Analytics for Post‑Surgical Dysphagia A recent systematic review and meta‑analysis identified seven variables that reliably predict dysphagia after oesophagectomy: age (OR 1.06 per year), lower body‑mass index (OR 0.96), tumor location in the upper or middle esophagus (OR 2.61), sarcopenia (OR 1.69 univariate, 3.42 multivariate), recurrent laryngeal … Read more

Base-Edited CAR T Cells: Remission in Leukemia & Transplant Progress

<h2>The Future of Cancer Treatment: Base-Edited CAR T-Cells and Beyond</h2> <p>A recent research highlight (dated January 30, 2026) signals a potential revolution in treating T cell acute lymphoblastic leukemia (T-ALL). Scientists are demonstrating success with base-edited CAR T-cells – a sophisticated form of immunotherapy. These aren’t just any CAR T-cells; they’re engineered to specifically target … Read more

EyeWorld Weekly, August 15, 2025

Eye on the Future: Breakthroughs and Trends in Ophthalmology The field of ophthalmology is on the cusp of transformative change. Driven by advances in gene therapy, innovative drug delivery systems, and surgical techniques, the future promises enhanced vision care for patients worldwide. Let’s delve into the key areas poised to revolutionize how we diagnose and … Read more

EMA Rejects Elevidys Gene Therapy for Duchenne

DMD Gene Therapy: Where Do We Go From Here? The recent decision by the European Medicines Agency (EMA) to not grant marketing authorization for delandistrogene moxeparvovec (Elevidys) for Duchenne muscular dystrophy (DMD) treatment highlights the complexities and challenges within gene therapy development. This news, coupled with serious safety concerns, prompts a crucial question: What’s next … Read more

AAV Gene Therapy for Deafness: Single-Arm Trial

The Future of Hearing Restoration: Gene Therapy’s Promising Horizon The world of audiology is undergoing a radical transformation. With advancements in gene therapy, the prospect of restoring hearing loss—once considered a distant dream—is rapidly becoming a tangible reality. This field, fueled by relentless research and innovation, is poised to redefine how we treat hearing impairments. … Read more

Nicole Verdun Exits FDA: Gene Therapy Regulator Departs

The FDA Shuffle: What the Departure of Key Players Means for Gene Therapy’s Future The recent shake-up within the Food and Drug Administration (FDA), specifically the removal of Nicole Verdun, director of the office overseeing cell and gene therapies, and her deputy Rachael Anatol, has sent ripples throughout the biotech world. But what does this … Read more

Personalized Gene Editing for Newborns: In Vivo Approach

The Rapid Rise of Personalized Base-Editing Therapies: What’s Next for Genetic Disease Treatment? Published: October 26, 2023 | Updated: October 26, 2023 The field of medicine is on the cusp of a revolution. Recent breakthroughs, such as the development of personalized base-editing therapies for rare genetic diseases, are paving the way for unprecedented advancements. This … Read more